Co-Founder, Chief Strategy And Business Development Officer
Current
Jun 2024 - Present
AeroLeads people directory · profile
Stephen A. Parent, Phd Email & Phone Number
Biotech Startup Founder, Entrepreneur and Business Development Strategist
at
Kathera Bioscience Inc.
1 work email found
@comcast.net
6 phones found area 908, 609, and 732
LinkedIn matched
✓ Verified May 2026
4 data sources
Profile completeness 100%
Current company
Role
Biotech Startup Founder, Entrepreneur and Business Development Strategist
Location
New York City Metropolitan Area, United States, United States
Who is Stephen A. Parent, Phd? Overview
A concise factual answer block for searchers comparing this professional profile.
Quick answer
Stephen A. Parent, Phd is listed as Biotech Startup Founder, Entrepreneur and Business Development Strategist at Kathera Bioscience Inc., based in New York City Metropolitan Area, United States, United States. AeroLeads shows a work email signal at comcast.net, phone signal with area code 908, 609, 732, and a matched LinkedIn profile for Stephen A. Parent, Phd.
Stephen A. Parent, Phd previously worked as Co-Founder, Chief Strategy and Business Development Officer at Kathera Bioscience Inc. and Co-Founder, VP Business Strategy & Development - Concurrent at Kathera Bioscience Inc.. Stephen A. Parent, Phd holds Ph.D., Molecular And Cell Biology from Brown University.
Company email context
Email format at Kathera Bioscience Inc.
This section adds company-level context without repeating Stephen A. Parent, Phd's masked contact details.
*@comcast.net
68% confidence
AeroLeads found 1 current-domain work email signal for Stephen A. Parent, Phd. Compare company email patterns before reaching out.
Profile bio
About Stephen A. Parent, Phd
I'm a founder of Kathera Bioscience and a pharma and biotech professional with more than 30 years of industry experience. KatheraBio’s mission is to treat serious, life-threatening fungal infections. Our company's name is derived from the Greek word "kathairó" meaning to cleanse. Kathera has successfully raised non-dilutive funding with a total value of up to $4.6 Million from the National Institute for Allergies and Infectious Disease (NIAID) and the New Jersey Economic Development Authority (NJEDA) Commission on Science and Technology (CSIT) to support its R&D programs.I have held Business Development and Alliance Management roles in Biotech companies Contract Research Organizations. My business development experience includes Sales, Licensing, Alliance Management and Contract Negotiation. I've also worked as an independent consultant through SP Pharma Consulting LLC, providing strategic advice to biotech companies in new technology development and evaluation, technology due diligence and antifungal drug R&D. At Merck & Co., I worked in drug discovery and preclinical development programs in therapeutic areas including infectious disease/antifungals, immunology and inflammation and sepsis. My group investigated the antifungal properties of the immunosuppressant FK-506 and played important roles identifying and characterizing FKS genes in budding yeast. Yeast Fks proteins are subunits of fungal beta-1,3-glucan synthase (GS), and targets of the first-in-class echinocandin drug CANCIDAS®. My lab also identified and characterized a murine gene encoding a C-type lectin expressed in subsets of immune sentinel dendritic cells. C-type lectins play important roles in pathogen pattern recognition, and regulation of host responses to bacteria, fungi and viruses. I am also a Founder of the BioPharma Networking Group (BPNG) founded in 2012. BPNG has several active regional networking groups in North America including NJ, PA, NY, MA, NC, IN, St Louis MO, and Toronto.
Listed skills include Drug Discovery, Biochemistry, Pharmaceutical Industry, Life Sciences, and 46 others.
Current workplace
Stephen A. Parent, Phd's current company
Company context helps verify the profile and gives searchers a useful next step.
15 roles · 46 years
Stephen A. Parent, Phd work experience
A career timeline built from the work history available for this profile.
Co-Founder, Vp Business Strategy & Development - Concurrent
Kathera Bioscience's (KatheraBio) mission is to treat serious, life-threatening fungal infections. The company has raised non-dilutive federal and state funding with a total value of up to $4.6 Million for our programs. Our company's name is derived from the Greek word "kathairó" meaning to cleanse. Fungal Infections are a major cause of human disease - an.
Jan 2020 - Jul 2024
Biotech Business Strategy & Development Consultant - Concurrent
CurrentAs the owner of SP Pharma Consulting LLC, I launched a biotech startup company, Kathera Bioscience, along with my scientific co-founder, to develop drugs to treat serious life-threatening fungal infections.SP Pharma Consulting provides services to the pharma, biotech and Contract Research Organizations. Clients leverage my experience and network for.
May 2009 - Present
Director, Business Strategy & Development
Oncobiologics is a U.S. based pure play biosimilar company developing, manufacturing and commercializing biosimilar versions of leading global biopharmaceuticals. My responsibilities included supporting Oncobiologics Senior Management with global business strategies and business development activities for biosimilar monoclonal antibodies and the platform.
Sep 2015 - Oct 2017
Director, Business Development
PBL Assay Science (Formerly PBL InterferonSource) began as the leading provider of products, services, information, and know-how related primarily to interferons. The pioneering interferon research conducted by its founder, Sidney Pestka, M.D., reflects decades of exploration into interferon's applications in medicine. The company has grown from start-up.
Apr 2013 - Sep 2015
Scientific Advisor
113 Industries' High-Speed Open Innovation processes assist Companies with Technology Mining, Technology Assessment and Opportunity Assessment, by enabling successfull adoption of External Discoveries through: 1) Assessing technologies critical to their business growth, 2) Achieving new revenue growth through rapid introduction of new products3) Building.
Jan 2012 - Apr 2013
Expert
YourEncore is a management consulting group of retired and veteran scientists and engineers, and provides clients with proven experience to help accelerate their pace of innovation. Experts collaborate with clients to add value and transfer their knowledge and insights.
Nov 2011 - Apr 2013
Director Of Business Development
Reaction Biology Corp. (RBC) is a Contract Research Organization that provides drug profiling, screening and early stage drug discovery collaborations. The company's proprietary radioisotopic HotSpot technology is an innovative, high-throughput platform for screening/profiling small molecules against any biological target which can be assayed with.
Mar 2011 - Aug 2011
Advisor And Visiting Professor
I served as an advisor for the Drug Discovery Tract of a new Master of Business and Science program being developed at the Rutgers University by Professor Charles E. Martin. In my role, I developed and taught the first "Drug Discovery Through Pre-Clinical Development" course with Gregory Ford. The core course is part of the Drug Discovery tract and.
Aug 2009 - Jun 2010
Director Of Sales And Business Development, North America
Euroscreen
Euroscreen SA is a world-renowed biotechnology company that specializes in G protein-coupled receptor (GPCR) research. In addition to its internal drug discovery programs, the Euroscreen-FAST business unit provides custom assay development and pharmacological profiling services, HTS screening capabilities and receptor deorphanization capabilities..
Jun 2009 - Apr 2010
Senior Research Fellow
Immunology & Rheumatology Department included: 1) Identified and validated new pain and osteoarthritis targets 2) Developed and managed in vitro and cell-based assays to support high thoughput screens, hit & lead identification, and lead optimization efforts on S1P, Osteoarthritis and Inflammatory Pain programs.3) Identified several S1P1-selective agonists.
2000 - 2008
~8 yrs
Senior Research Fellow
Infectious Disease Department: 1) Identified and validated new antifungal targets2) Developed and managed cell-based and in vitro assays to identify new antifungal leads against an essential fungal peptidyl-prolyl isomerase (PPIase).3) Managed development of assays to detect inhibitors of fungal mRNA capping, screened natural products and identified.
1996 - 1999
~3 yrs
Research Fellow
Natural Products Program:1) Researched mechanism of action of immunosuppressants FK506 and CsA and determined that antifungal properties are mechanistically related to immunosuppressive properties. 2) Developed cell-based assays to detect and characterize immunosuppressive compounds in natural products. 3) Researched mechanism of action of echinocandin.
1987 - 1996
~9 yrs
Senior Research Microbiologist
I managed development of assays to identify new antifungal drugs and initiated efforts to evaluate use of yeast cell-based Ty transposon assays to identify new compounds that inhibit the HIV life cycle. I designed artificial intron in Saccharomyces cerevisiae PHO5 gene, and developed/validated cell-based screen for discovery of natural product antifungals.
1987 - 1992
~5 yrs
Graduate Student And Postdoc
1980 - 1987
~7 yrs
4 education records
Stephen A. Parent, Phd education
Ph.D., Molecular And Cell Biology
Brown University
Mini-Mba Certificate Programs
Rutgers University
Postdoc Fellow, Biochemistry And Molecular Biology
Brown University
B. Sc. With High Distinction, Life Sciences
Worcester Polytechnic Institute
FAQ
Frequently asked questions about Stephen A. Parent, Phd
Quick answers generated from the profile data available on this page.
What company does Stephen A. Parent, Phd work for?
Stephen A. Parent, Phd works for Kathera Bioscience Inc..
What is Stephen A. Parent, Phd's role at Kathera Bioscience Inc.?
Stephen A. Parent, Phd is listed as Biotech Startup Founder, Entrepreneur and Business Development Strategist at Kathera Bioscience Inc..
What is Stephen A. Parent, Phd's email address?
AeroLeads has found 1 work email signal at @comcast.net for Stephen A. Parent, Phd at Kathera Bioscience Inc..
What is Stephen A. Parent, Phd's phone number?
AeroLeads has found 6 phone signal(s) with area code 908, 609, 732 for Stephen A. Parent, Phd at Kathera Bioscience Inc..
Where is Stephen A. Parent, Phd based?
Stephen A. Parent, Phd is based in New York City Metropolitan Area, United States, United States while working with Kathera Bioscience Inc..
What companies has Stephen A. Parent, Phd worked for?
Stephen A. Parent, Phd has worked for Kathera Bioscience Inc., Sp Pharma Consulting Llc, Oncobiologics Inc., Pbl Assay Science, and 113 Industries.
How can I contact Stephen A. Parent, Phd?
You can use AeroLeads to view verified contact signals for Stephen A. Parent, Phd at Kathera Bioscience Inc., including work email, phone, and LinkedIn data when available.
What schools did Stephen A. Parent, Phd attend?
Stephen A. Parent, Phd holds Ph.D., Molecular And Cell Biology from Brown University.
What skills is Stephen A. Parent, Phd known for?
Stephen A. Parent, Phd is listed with skills including Drug Discovery, Biochemistry, Pharmaceutical Industry, Life Sciences, Molecular Biology, Immunology, Cell Biology, and In Vitro.
Find 750M verified contacts
Search by job title, company, industry, location, and seniority. Export verified B2B contact data when you need it.
Start free trial